Crystagen 10mg

Crystagen 10 mg is a high-purity lyophilized peptide research compound supplied exclusively for scientific investigation and controlled laboratory experimentation.

For research use only — not for human or veterinary use.

Product Overview

Crystagen is a synthetic peptide research compound developed for advanced laboratory investigations involving peptide biology, intracellular signalling, molecular communication and cellular regulatory pathways.

Its compact molecular structure and highly reproducible analytical profile have attracted growing scientific interest within peptide research, where investigators continue to explore peptide-mediated biochemical mechanisms under carefully controlled laboratory conditions.

This preparation contains 10 mg of lyophilized Crystagen supplied in a sealed research vial. Independent analytical testing confirmed an assay content of 17.12 mg for this production batch. Lyophilization preserves peptide stability during storage while allowing controlled reconstitution for laboratory experimentation.

With its verified molecular identity, exceptional analytical purity and comprehensive third-party quality control, Crystagen provides a reliable research material suitable for advanced peptide investigations and controlled in vitro laboratory studies.

Peptide Overview

Crystagen is a synthetic peptide research compound commonly utilised in laboratory investigations involving peptide chemistry, molecular biology and intracellular communication systems.

Researchers employ Crystagen in controlled experimental models designed to investigate peptide-mediated interactions, biochemical regulatory pathways, molecular signalling mechanisms and cellular communication networks.

Its reproducible analytical characteristics, consistent manufacturing quality and stable molecular profile have established Crystagen as a valuable compound within modern peptide research.

Today, Crystagen continues to appear throughout scientific literature involving peptide pharmacology, molecular biology, biochemical regulation and experimental peptide investigations.

Historical Background and Scientific Context

Advances in peptide synthesis and molecular biology have enabled researchers to investigate increasingly specialised synthetic peptides capable of supporting detailed laboratory studies involving intracellular communication, molecular signalling and biochemical regulation.

Modern analytical technologies including ultra-high-performance liquid chromatography, FTIR spectroscopy and high-resolution mass spectrometry provide comprehensive verification of peptide identity, purity and manufacturing consistency for research-grade peptide compounds.

As peptide science continues to evolve, compounds such as Crystagen contribute to controlled laboratory investigations involving peptide biology, molecular pharmacology, receptor biology and cellular signalling research.

Today, Crystagen remains part of the expanding collection of investigational peptides utilised exclusively for scientific research and in vitro laboratory experimentation.

Mechanistic Focus in Research

Within controlled laboratory environments, Crystagen is commonly investigated in relation to peptide signalling and intracellular molecular communication.

Research investigations frequently explore:

• Peptide signalling pathways
• Intracellular communication systems
• Cellular regulatory mechanisms
• Molecular interaction dynamics
• Biochemical pathway investigations
• Comparative peptide research
• Controlled molecular signalling studies

These experimental models allow researchers to investigate complex peptide-mediated biochemical mechanisms while maintaining carefully controlled laboratory conditions.

Analytical Verification (COA)

Each batch of Crystagen supplied by Grail Formula undergoes comprehensive independent third-party laboratory verification to confirm peptide identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic, spectrometric, microbiological and mass spectrometry techniques.

Batch: GF-CRYSTA10-B241

• Assay Content: 17.12 mg
• Purity: greater than 99.8 percent
• Identification by FTIR Spectrum: 997
• Identification by Retention Time: 0.998
• Molecular Ion Mass Identification: 359 Da
• Bacterial Endotoxins: 0.135 EU/mg
• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g

Independent elemental impurity analysis confirmed no detectable arsenic, cadmium, cobalt, lead, mercury, nickel or vanadium, with all measured concentrations remaining below the laboratory detection limit.

Additional microbiological testing confirmed no detectable aerobic microorganisms, yeasts or moulds, supporting laboratory-grade quality standards suitable for controlled scientific investigation.

These analytical procedures provide confirmation of peptide identity, purity, traceability and batch consistency while ensuring every production batch meets Grail Formula’s strict research quality standards.

Research Applications

Within controlled laboratory environments, Crystagen may be utilised in experimental models designed to investigate peptide biology, intracellular signalling pathways, molecular communication systems and biochemical regulatory mechanisms.

Examples of research applications include:

• Peptide biology investigations
• Intracellular signalling research
• Molecular pathway analysis
• Biochemical regulation studies
• Comparative peptide investigations
• Cellular communication research
• Controlled in vitro peptide studies

These applications are intended exclusively for scientific and laboratory investigation.

Grail Formula Quality

Every Grail Formula research compound is manufactured under strict quality control procedures and supported by comprehensive independent analytical verification.

Each production batch undergoes extensive testing to verify:

• Peptide identity confirmation
• Assay content verification
• Purity assessment
• Molecular ion mass verification
• Retention time confirmation
• FTIR spectrum identification
• Endotoxin analysis
• Microbial contamination screening
• Heavy metal screening
• Complete batch traceability

Independent laboratory testing helps ensure every batch provides reliable, reproducible research material suitable for advanced scientific investigation.

When You Choose Grail Formula

When selecting Grail Formula, researchers receive independently verified research compounds supported by complete Certificates of Analysis and transparent batch-specific laboratory documentation.

Our analytical verification programme includes assay determination, purity confirmation, FTIR spectrum identification, retention time verification, molecular ion mass identification, endotoxin screening, microbiological analysis and comprehensive heavy metal testing.

Every production batch is accompanied by a downloadable Certificate of Analysis issued by Liquilabs s.r.o. Czechia, providing complete traceability, independent verification and confidence in the analytical quality of every research compound supplied.

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• Purity greater than 99.8 % confirmed by COA
• Assay content verified at 17.12 mg
• Identification confirmed by FTIR spectrum and retention time analysis
• Molecular ion mass identified at 359 Da
• Bacterial endotoxin level 0.135 EU/mg
• No detectable heavy metals or microbial contamination
• Research-grade peptide compound
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.